HomepageProducts & ServicesNews > HemoSonics Point-Of-Care Viscoelastic testing system used for COVID19 patients

HemoSonics Point-Of-Care Viscoelastic testing system used for COVID19 patients

Back to list

Recent clinical reports have shown that patients with severe COVID-19 infection can develop a coagulopathy that is likely triggered by the acute inflammatory response. How do you ensure safe and efficient coagulation monitoring at the point of care and minimize staff exposure?

The Quantra® Hemostasis Analyzer, with its QPlus® and QStat® cartridges, represents the only VET (viscoelastic testing) system specifically designed and optimized for point of care use, with a completely enclosed system and no open-tube blood manipulation required after sample collection.

Initiates file downloadClick here to download our Flyer

Top